Clinical Regulatory Services | Clinical & Non-Clinical Regulatory Support
Specialist clinical regulatory services for pharmaceutical and medical device companies — delivered by RABT Global’s expert regulatory team.
Clinical regulatory services and non-clinical regulatory services are the foundation of the drug development and medical device approval process. The regulatory requirements governing clinical trials, preclinical studies, and safety assessments are highly technical and constantly evolving — requiring specialist expertise to navigate effectively. From early-phase IND and CTA submissions through to clinical study report preparation, post-market clinical follow-up (PMCF), and nonclinical safety regulatory reports, RABT Global’s clinical and non-clinical regulatory services support every stage of your product’s development lifecycle.
How RABT Global Delivers This Service
Initial Consultation & Needs Assessment
We review your specific clinical regulatory services requirements, target markets, and timelines to scope the engagement.
Strategy & Planning
Our specialist team develops a tailored approach aligned with applicable regulatory requirements and your commercial objectives.
Delivery & Execution
We execute the defined scope — producing regulatory-compliant deliverables to the highest quality standards.
Review & Quality Assurance
All deliverables undergo independent review and quality check before client delivery.
Ongoing Support
RABT Global remains available for follow-up queries, regulatory authority interactions, and lifecycle support.
Our Clinical & Non-Clinical Regulatory Services
IND / CTA Preparation & Submission
Investigational New Drug (IND) and Clinical Trial Application (CTA) preparation for FDA, EMA, MHRA, and CDSCO
Clinical Development Regulatory Strategy
regulatory planning for Phase I–III clinical programmes aligned with health authority expectations
Clinical Trial Regulatory Consulting
protocol design review, clinical trial monitoring, IMPD preparation
Regulatory Support for Clinical Trials
GCP compliance support, ethics committee liaison, and trial registration management
Non-Clinical Regulatory Services
integrated non-clinical summary preparation (CTD Module 4) and regulatory review of study protocols
Nonclinical Safety Regulatory Support
toxicology package review, ICH guidelines compliance, safety study design advisory
Early Phase Regulatory Consulting
First-in-Human (FIH) study regulatory strategy, NOAEL assessment, dose justification
Clinical Lifecycle Regulatory Services
post-approval clinical obligations, PMCF planning, registry studies, and PASS
What are Clinical & Non-Clinical Regulatory Services?
Clinical & Non-Clinical Regulatory Services provide life sciences companies with specialist clinical regulatory services expertise — supporting regulatory compliance, market access, and product lifecycle management across pharmaceutical and medical device sectors. RABT Global’s clinical regulatory services are delivered by qualified regulatory professionals with deep expertise in FDA, EMA, MHRA, CDSCO, and global regulatory requirements.
Clinical & Non-Clinical Regulatory Services — FAQs
A: An Investigational New Drug (IND) application is required by the FDA before clinical trials of an investigational drug product can begin in the United States. The IND contains preclinical safety data, the clinical protocol, and investigator information. RABT Global’s IND/CTA regulatory services manage the complete IND preparation and submission process, including pre-IND meeting strategy and FDA response management.
A: Clinical regulatory services cover the regulatory aspects of human clinical trials — including IND/CTA preparation, protocol design review, ethics committee liaison, and clinical data regulatory support. Non-clinical (or preclinical) regulatory services cover the regulatory aspects of animal studies, in vitro testing, and safety pharmacology — including toxicology protocol review, non-clinical summary preparation, and ICH guideline compliance. RABT Global provides both, integrated as part of a comprehensive development regulatory programme.
A: RABT Global combines specialist clinical regulatory services expertise with a proven track record across 200+ global clients. Our regulatory team brings multi-jurisdictional knowledge, integrated regulatory and medical writing capabilities, and a genuine partnership approach — making us the clinical regulatory services provider of choice for pharmaceutical and medical device companies worldwide.
Expert Clinical & Non-Clinical Regulatory Services — Partner with RABT Global
Get specialist clinical regulatory services from RABT Global’s expert regulatory team. Trusted by 200+ life sciences companies worldwide.